Urvi M Parikh

10PUBLICATIONS
31CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Behavioural epidemiologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
Selection of Mutations in HIV-1 Nucleocapsid and Integrase in Individuals Living with HIV Experiencing Virologic Failure After Initiating or Switching to Tenofovir-Lamivudine-Dolutegravir.

|Feb 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.

Davey Smith, Isabelle R Weir, Sydney Ramirez

|Nov 03, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083.

Hannah P Moore, Jessica M Fogel, Mark A Marzinke

|Aug 21, 2025
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa.

Urvi M Parikh, Lauren D Kudrick, Lisa Levy

|Jul 02, 2025
HIV-1 testing in the context of expanding PrEP modalities.

Urvi M Parikh, Jana L Jacobs, Njambi Njuguna

|Sep 21, 2023
Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial.

Urvi M Parikh, Kerri J Penrose, Amy L Heaps

Pageof 2

Frequent Collaborators

2 joint publications

Kerri J Penrose

1 joint publications

Robert Glaubius

1 joint publications

Ume L Abbas

1 joint publications

Thesla Palanee-Phillips